Tardive Dystonia and the Use of Cannabis (letter/ forum repost – 2010) http/www.420magazine.com/forums/dystonia/169902-tardive-dystonia-use-cannabis.html
Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21029743
Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia (abst - 2011) http/www.ncbi.nlm.nih.gov/pubmed/21266946
The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats. (abst – 2011) http/www.unboundmedicine.com/medline/ebm/record/20888328/abstract/The_effects_of_cannabinoid_drugs_on_abnormal_invol untary_movements_in_dyskinetic_and_non_dyskinetic_ 6_hydroxydopamine_lesioned_rats_
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3273613/
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24140894
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http/www.neurology.org/content/82/17/1556.long
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24599755
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24747871
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia (abst – 2014) http/onlinelibrary.wiley.com/doi/10.1002/syn.21740/abstract
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25486547
Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21029743
Association study of Cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia (abst - 2011) http/www.ncbi.nlm.nih.gov/pubmed/21266946
The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats. (abst – 2011) http/www.unboundmedicine.com/medline/ebm/record/20888328/abstract/The_effects_of_cannabinoid_drugs_on_abnormal_invol untary_movements_in_dyskinetic_and_non_dyskinetic_ 6_hydroxydopamine_lesioned_rats_
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3273613/
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24140894
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. (full – 2014) http/www.neurology.org/content/82/17/1556.long
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24599755
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24747871
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental l-DOPA-induced dyskinesia (abst – 2014) http/onlinelibrary.wiley.com/doi/10.1002/syn.21740/abstract
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25486547